French food product conglomerate Danone is said to be in “advanced” discussions with Swiss confectioner Nestle to divest its medical nutrition operations after healthcare firm Fresenius dropped out of the acquisition race.
According to unnamed sources, Nestle is poised to acquire the nutrition operations, though any buy would face antitrust hurdles in certain western Europe markets, they said. Further, they told reporters, the acquisition could raise more than $4 billion for Danone.
Germany-based Fresenius was once considered a front-runner for the purchase but is reportedly no longer interested in a deal.
All three parties declined to comment on the matter, reports said.
Full content: Business Report
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Judge Mehta Questions Both Sides in Landmark Google Antitrust Case
May 2, 2024 by
CPI
FCC Urges Urgent Funding for Removal of Chinese Telecom Equipment from U.S. Networks
May 2, 2024 by
CPI
Former Pioneer CEO Facing Potential Criminal Charges For Colluding With OPEC
May 2, 2024 by
CPI
South Korea’s Antitrust Regulator Greenlights K-Pop Powerhouse Deal
May 2, 2024 by
CPI
Exxon’s Pioneer Purchase Approved, Former CEO Barred from Board
May 2, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Economics of Criminal Antitrust
Apr 19, 2024 by
CPI
Navigating Economic Expert Work in Criminal Antitrust Litigation
Apr 19, 2024 by
CPI
The Increased Importance of Economics in Cartel Cases
Apr 19, 2024 by
CPI
A Law and Economics Analysis of the Antitrust Treatment of Physician Collective Price Agreements
Apr 19, 2024 by
CPI
Information Exchange In Criminal Antitrust Cases: How Economic Testimony Can Tip The Scales
Apr 19, 2024 by
CPI